Revvity Inc. (RVTY) - Total Liabilities
Based on the latest financial reports, Revvity Inc. (RVTY) has total liabilities worth $4.81 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Revvity Inc. - Total Liabilities Trend (1985–2025)
This chart illustrates how Revvity Inc.'s total liabilities have evolved over time, based on quarterly financial data. See Revvity Inc. (RVTY) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Revvity Inc. Competitors by Total Liabilities
The table below lists competitors of Revvity Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CACI International Inc
NYSE:CACI
|
USA | $7.32 Billion |
|
Subsea 7 S.A.
OL:SUBC
|
Norway | Nkr4.03 Billion |
|
AAON Inc
NASDAQ:AAON
|
USA | $855.50 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $77.30 Million |
|
China Railway Construction Corp Ltd
SHG:601186
|
China | CN¥1.70 Trillion |
|
American Financial Group, Inc.
NYSE:AFG
|
USA | $21.16 Billion |
|
Hero MotoCorp Limited
NSE:HEROMOTOCO
|
India | Rs116.42 Billion |
|
Absa Group Ltd
JSE:ABG
|
South Africa | ZAC1.97 Trillion |
Liability Composition Analysis (1985–2025)
This chart breaks down Revvity Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Revvity Inc. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revvity Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revvity Inc. (1985–2025)
The table below shows the annual total liabilities of Revvity Inc. from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.92 Billion | +4.07% |
| 2024-12-31 | $4.73 Billion | -16.98% |
| 2023-12-31 | $5.69 Billion | -15.64% |
| 2022-12-31 | $6.75 Billion | -14.15% |
| 2021-12-31 | $7.86 Billion | +86.03% |
| 2020-12-31 | $4.22 Billion | +13.43% |
| 2019-12-31 | $3.72 Billion | +9.86% |
| 2018-12-31 | $3.39 Billion | -5.51% |
| 2017-12-31 | $3.59 Billion | +69.01% |
| 2016-12-31 | $2.12 Billion | +3.27% |
| 2015-12-31 | $2.06 Billion | -1.42% |
| 2014-12-31 | $2.09 Billion | +6.83% |
| 2013-12-31 | $1.95 Billion | -0.50% |
| 2012-12-31 | $1.96 Billion | -2.56% |
| 2011-12-31 | $2.01 Billion | +56.86% |
| 2010-12-31 | $1.28 Billion | -10.25% |
| 2009-12-31 | $1.43 Billion | +4.86% |
| 2008-12-31 | $1.36 Billion | -0.74% |
| 2007-12-31 | $1.37 Billion | +47.34% |
| 2006-12-31 | $932.59 Million | -10.58% |
| 2005-12-31 | $1.04 Billion | -6.50% |
| 2004-12-31 | $1.12 Billion | -11.38% |
| 2003-12-31 | $1.26 Billion | -20.53% |
| 2002-12-31 | $1.58 Billion | -1.40% |
| 2001-12-31 | $1.61 Billion | +10.03% |
| 2000-12-31 | $1.46 Billion | +25.45% |
| 1999-12-31 | $1.16 Billion | +57.46% |
| 1998-12-31 | $739.10 Million | +46.71% |
| 1997-12-31 | $503.80 Million | +10.05% |
| 1996-12-31 | $457.80 Million | +4.76% |
| 1995-12-31 | $437.00 Million | +25.68% |
| 1994-12-31 | $347.70 Million | +19.36% |
| 1993-12-31 | $291.30 Million | +5.51% |
| 1992-12-31 | $276.10 Million | -0.40% |
| 1991-12-31 | $277.20 Million | -9.29% |
| 1990-12-31 | $305.60 Million | +3.80% |
| 1989-12-31 | $294.40 Million | +42.22% |
| 1988-12-31 | $207.00 Million | -15.20% |
| 1987-12-31 | $244.10 Million | +16.85% |
| 1986-12-31 | $208.90 Million | -7.73% |
| 1985-12-31 | $226.40 Million | -- |
About Revvity Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more